H Vinazzer

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Substitution of antithrombin III in shock and DIC: A randomized study

B. Blauhut, H. Kramar, H Vinazzer et al. · Thrombosis Research · 1985 · 205 citations

Thrombosis, Randomized Study, Hematology +9

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

V V Kakkar, O. Boeckl, B Boneu et al. · World Journal of Surgery · 1997 · 98 citations

Substitution therapy with an antithrombin III concentrate in shock and DIC

B. Blauhut, S Necek, H Vinazzer et al. · Thrombosis Research · 1982 · 92 citations

Thrombosis, Substitution Therapy, Hematology +8

Dose-Dependent Influence of Acetylsalicylic Acid on Platelet Functions and Plasmatic Coagulation Factors

D Loew, H Vinazzer · Pathophysiology of Haemostasis and Thrombosis · 1976 · 67 citations

Dose-dependent Influence, Hypertension, Pharmacotherapy +20